Can I read The Role of Diet and Drugs in Lowering Serum Cholesterol in the Postmyocardial Infarction Patient on EtoBox?

The Role of Diet and Drugs in Lowering Serum Cholesterol in the Postmyocardial Infarction Patient by G. Schettler is a Medicine article available to read on EtoBox.

What is The Role of Diet and Drugs in Lowering Serum Cholesterol in the Postmyocardial Infarction Patient about?

Lipid disorders are the most important factors in the development of coronary heart disease (CHD). They need to be treated in primary as well as in secondary prevention. U.S. and European Consensus Conferences agreed that desirable serum cholesterol levels should not exceed 200 mg/dL. When baseline cholesterol averages above 250 mg/dL, the minimum requirement for characterizing the lipoprotein disorder is measurement of cholesterol, triglycerides, and highdensity lipoprotein (HDL) in the fasting state. In selecting targets for serum lipid values, it may be taken into account that CHD incidence is lowest in persons with serum cholesterol below 180 mg/dL. Any kind of lipid-lowering therapy should be commenced with dietary treatment. If this is ineffective, drugs may be applied additionally. Possible causes of secondary hyperlipidemia should be excluded. There is no strict age limit for treatment but the subject's cardiovascular status should be examined carefully, especially in secondary prevention. The patient in whom extensive myocardial damage is the main arbiter of prognosis is unlikely to gain from strenuous efforts aimed at retarding progression of atheromata, the major causes

Who reads The Role of Diet and Drugs in Lowering Serum Cholesterol in the Postmyocardial Infarction Patient?

Author

G. Schettler

Publisher

Springer US; Springer-Verlag; Kluwer Academic Publishers; Springer Science and Business Media LLC (ISSN 0920-3206)

Published

1989

Language

EN

Field

Medicine (Health Sciences)